TP53 and lung adenocarcinoma: Overall, these observations highlight p53 signaling and plasminogen activator pathways as critical signaling events that are perturbed downstream of mutations in TSHZ3 and SETD2, proposing a role for these mutations in lung adenocarcinoma tumorigenesis.